Tom Frohlich
Chief Executive Officer at Jade Biosciences Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2025
2 years of board service in total across 1 board, counting each seat separately. Longest: Jade Biosciences Inc., 1 year.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Jade Biosciences Inc. June 8, 2026100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 12, 2026 | Jade Biosciences Inc. | Grant or award | +78,750 | — | — |
| May 16, 2025 | Jade Biosciences Inc. | Open-market purchase | +6,000 | $7.40 | $44,400 |
Questions about Tom Frohlich
What boards is Tom Frohlich on?
Tom Frohlich sits on the board of Jade Biosciences Inc.
What company is Tom Frohlich the CEO of?
Tom Frohlich has been Chief Executive Officer of Jade Biosciences Inc. since April 2025.
How long has Tom Frohlich served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2025.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.